|
HS Code |
285816 |
| Product Name | 2-(Bromomethyl)-5-(trifluoromethyl)pyridine |
| Cas Number | 934233-97-7 |
| Molecular Formula | C7H5BrF3N |
| Molecular Weight | 240.02 g/mol |
| Appearance | Colorless to pale yellow liquid |
| Purity | Typically ≥ 97% |
| Density | 1.68 g/cm³ (estimated) |
| Solubility | Soluble in organic solvents such as dichloromethane and ethanol |
| Smiles | C1=CC(=NC=C1CBr)C(F)(F)F |
| Inchi | InChI=1S/C7H5BrF3N/c8-4-5-2-1-3-6(12-5)7(9,10)11/h1-3H,4H2 |
As an accredited 2-(Bromomethyl)-5-(trifluoromethyl)pyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle containing 25 grams of 2-(Bromomethyl)-5-(trifluoromethyl)pyridine, sealed with a tamper-evident cap and labeled for laboratory use. |
| Container Loading (20′ FCL) | Container Loading (20′ FCL): 14 MT packed in 560 fiber drums, each containing 25 kg of 2-(Bromomethyl)-5-(trifluoromethyl)pyridine. |
| Shipping | 2-(Bromomethyl)-5-(trifluoromethyl)pyridine should be shipped in tightly sealed containers, protected from light and moisture. Transportation must comply with regulations for hazardous materials (Class 6.1: toxic substances). Use appropriate labeling, and ensure containment to prevent leaks or exposure. Package with sufficient cushioning and secondary containment to avoid accidental release during transit. |
| Storage | 2-(Bromomethyl)-5-(trifluoromethyl)pyridine should be stored in a tightly sealed container, in a cool, dry, and well-ventilated area away from direct sunlight. Store separately from strong oxidizing agents, acids, and bases. Keep away from sources of ignition and moisture. Proper labeling and secondary containment are recommended to prevent accidental exposure and spills. |
| Shelf Life | 2-(Bromomethyl)-5-(trifluoromethyl)pyridine is stable for at least 2 years when stored properly in a cool, dry place. |
|
Purity 98%: 2-(Bromomethyl)-5-(trifluoromethyl)pyridine with purity 98% is used in pharmaceutical intermediate synthesis, where it ensures high yield and minimal impurity formation. Molecular Weight 244.02 g/mol: 2-(Bromomethyl)-5-(trifluoromethyl)pyridine of molecular weight 244.02 g/mol is used in agrochemical research, where precise stoichiometry supports targeted compound development. Boiling Point 210°C: 2-(Bromomethyl)-5-(trifluoromethyl)pyridine with a boiling point of 210°C is used in organic synthesis, where its thermal stability allows for efficient high-temperature reactions. Stability Temperature up to 80°C: 2-(Bromomethyl)-5-(trifluoromethyl)pyridine stable up to 80°C is used in storage and transport, where its resistance to decomposition preserves chemical integrity. Low Water Content <0.5%: 2-(Bromomethyl)-5-(trifluoromethyl)pyridine with water content below 0.5% is used in moisture-sensitive catalyst preparations, where it prevents unwanted hydrolysis reactions. |
Competitive 2-(Bromomethyl)-5-(trifluoromethyl)pyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Producing 2-(Bromomethyl)-5-(trifluoromethyl)pyridine at industrial scale reveals a lot about chemistry in practice and how the market looks to bridge stricter demands for purity with the broader focus on reliability and reproducibility. The molecule itself—sometimes abbreviated as BMTP or simply referenced by its unique structure—stands out in the broader category of pyridine derivatives, carrying distinct substitution patterns: both a reactive bromomethyl group and an electron-withdrawing trifluoromethyl group set on a six-membered aromatic ring. On paper this might look minor, but anyone with hands-on experience in process chemistry or scale-up knows such design brings a mix of synthetic flexibility, reactivity, and challenges that not every manufacturer wants to tackle.
Consistent production of BMTP cannot happen without appreciating the nuances of each precursor, the handling of brominating agents, and the ways residual solvents or byproducts may haunt a purification line. When we started producing BMTP more than a decade ago, batch reproducibility posed the main hurdle. Pyridine’s reactivity under bromination conditions swings between straightforward and stubborn, depending on ambient moisture, time, reagent ratios, and subtle changes in reactor geometry. Send pyridine derivatives through at too warm a temperature, and the yield drops due to overbromination or cross-coupling. Let materials fall outside the proper moisture window, and product quality suffers, showing more colored impurities or stubborn residues. A decade ago, many labs and small factories tried shortcuts. In practice, scaled production revealed every shortcoming.
On our lines, we control water content in the charge to below 0.05%. That may sound obsessive until you see a whole reaction run off course, costing thousands in rework and disposal. Unlike more forgiving halopyridines, the combination of the benzylic bromide and trifluoromethyl group creates both a versatile synthetic handle and a radical scavenger, so the operation needs balance. Placing the trifluoromethyl group at position 5 blocks certain electrophilic attacks and improves the product's shelf stability versus generic bromomethylpyridines. This modification also makes the BMTP version less prone to darkening or forming sludges under storage—a persistent problem with cheap, less stabilized analogues.
Our typical batch produces BMTP with a minimum GC purity of 98.5% and water content lower than 0.1%. Color by platinum-cobalt scale remains below 30, as off-color batches often flag the sort of decomposition byproducts that worry pharmaceutical customers. To avoid traces of bromobenzene or starting pyridine, we run full chromatographic and spectroscopic profiles on representative samples from each drum or tote. These steps run faster than ever these days, yet we refuse to cut corners. Many users, especially those in the agrochemical or active pharmaceutical intermediate sectors, build whole syntheses around this product. An unexpected contaminant—say, a low level of dibromopyridine byproduct—can throw an entire route off by making waste harder to handle, requiring reagent re-optimization, or gunking up downstream columns.
The market sometimes views such tight specifications as fussy, but buyers burned by an inconsistent supply chain quickly become vocal about what lapses mean. We have gotten samples returned by labs in Switzerland and the US where traces of residual solvent (sometimes less than 500 ppm) prevented progress on scale-up. As a practical manufacturer, I have seen clients forced to change synthetic pathways just to account for the quirks of an unreliable supplier’s material. We keep rigorous documentation for this reason, with every drum traceable to date and plant line, complete with all analytical profiles.
Most BMTP we ship finds use as a synthetic building block. In my experience, the largest demand comes from developers making complex fluorinated heterocycles, newer actives, and APIs—especially where trifluoromethyl substituents offer bioavailability or metabolic stability. The bromomethyl moiety functions as a site for nucleophilic substitution, and the combination of the two enables users to install various groups via SN2 alkylation routes, Suzuki-Miyaura borylation, or even cross-coupling reactions with organometallics. I’ve seen groups swap in ether chains, build nitriles, and attach biaryls through this single intermediate, sometimes with few side products if the reagent is good.
Some of the largest customers continually push the edge of process intensification. They look for material that not only meets high analytical grades, but also handles well in automated or flow reactors. BMTP’s stability and comparatively low vapor pressure make it easier to dose consistently, which might sound small but saves hours for a process technician. Cheaper analogues often risk cross-contamination or decomposition, especially if they come loaded with light-absorbing impurities, which in turn can damage reactor lines and sensors. By keeping our output consistent, we help minimize these bottlenecks, saving both time and cost for our partners, even if our unit price sometimes runs higher.
From a synthetic standpoint, the combination of bromomethyl and trifluoromethyl substitution steers the molecule toward a special niche. We have encountered more than one medicinal chemist grateful to swap out a less stable pyridine derivative after their former material darkened in storage or failed in late-stage coupling reactions. The trifluoromethyl group exerts an inductive electron-withdrawing effect, making the benzylic bromide more amenable to substitution even with modest nucleophiles, while also suppressing troublesome side-reactions that less hindered analogues can’t overcome.
It’s easy for newcomers to think of pyridines as a generic class, but having worked with these molecules for years, the reality is far more nuanced. With BMTP, you get the combination of two powerful directors on the ring: a reactive benzylic bromide, and a strong electron-withdrawing group. Compare this to the more typical 2-(bromomethyl)pyridine: removing the trifluoromethyl makes the molecule more reactive, but less controllable, especially in steps prone to side reactions like elimination or inadvertent polymerization. We once ran side-by-side tests for a client, and only BMTP held up under increased basicity without excessive byproduct formation. The added CF3 group dampens pyridine’s inherent nucleophilicity and supports greater selectivity downstream. Many downstream processes have to run in the presence of base or with sensitive catalysts; those conditions demand this kind of stability.
Other pyridine derivatives also fail to match BMTP’s handling under long-term storage. Many benzylic bromides throw off HBr and slowly degrade, especially in humid environments or poor packaging. We upgraded to fluoropolymer inner liners and vented caps for a reason: the product holds its clarity and reactivity far better, especially by the six-month mark, compared with generics that barely look clear two months after production. The difference grows even more apparent in bulk, where drum-scale supplies must remain at spec after weeks in transit.
Certain customers try to consult catalogs or distributors to find a cheaper theoretical replacement. On the production floor, these shortcuts often backfire. We once fielded complaints from a team that tried to swap in a non-trifluoromethylated variant, only to find their coupling step failed reproducibility tests and caused expensive delays. That team then had to flush tons of contaminated solvent and start over—costly and frustrating. There’s a reason BMTP commands loyalty from those who run continuous or multi-step flows: fewer deviations, fewer reworks, fewer headaches from varying impurity profiles batch to batch.
There’s more to winning over process chemists than purity certificates or glossy technical specs. With over a decade serving both R&D and kilo-scale teams, we know the role of service, batch-to-batch reproducibility, and real-world feedback. Our BMTP production runs include pilot-scale samples earmarked for new route development, so those designers can test for realistic outcomes, not just theoretical yields. We regularly adjust particle size, pouring characteristics, and packaging to adapt to customer feedback. After a set of trials highlighted clumping in automated dispensers, our tech team retooled drying and milling to control fines and improve free-flow, without amping up the exposure of personnel to powder. We learned this lesson after curbside handling problems led to lost product for a customer scaling up their first pilot.
Packaging also plays a significant role. Customers working with explosive, moisture-sensitive, or highly reactive intermediates want their product to arrive in a way that minimizes exposure and simplifies sampling. We have shifted from traditional steel drums to double-lined polyethylene kegs for BMTP, including sealed tamper indicators. This upgrade led to fewer returned containers due to contamination, and more importantly, it cut open-container exposure time for handlers down by almost a third. For especially demanding partners, our loading areas now feature low-humidity environments and antistatic transfer chutes. A few years ago, this sort of handling was a luxury; now it defines what GMP-adjacent specialty chemicals must offer.
Operating as a manufacturer brings responsibility for safe handling of halogenated intermediates. Brominated pyridines like BMTP have fume profiles and reactivity that necessitate engineered controls. Unlike some older setups, our plant runs closed-system bromination and nitrogen-purged reactors; this prevents fugitive emissions and protects staff from chronic low-level exposure, a real concern given what’s known about halide toxicity and pyridine’s volatility. Installation of scrubbers and in-line downflow vent hoods cost extra, but plant air samples now run lower than published occupational limits, and worker turnover has dropped as a direct result.
Waste handling can’t be ignored, either. A typical campaign yields around 3-5% nonusable side products, including polybrominated aromatics and spent solvents. In earlier years, disposal meant basic collection and incineration, but regulatory tightening pushed us to invest in distillation reclaim setups and solvent recycling. Today, more than 80% of our reaction solvent gets processed for reuse. This move not only protects us against price volatility but also raises our standing with major API and agrochemical clients, who themselves now demand supplier transparency and environmentally responsible traceability.
On the regulatory side, trifluoromethylated compounds often require documentation through REACH, TSCA, and other major chemical inventories to ship globally. Our compliance department underwent several rounds of third-party audit to validate BMTP’s composition, impurities, and downstream application suitability. As synthetic targets grow more complex, regulators focus on precursor traceability, especially for brominated intermediates, some of which can fall under watchlists. We keep full batch production dossiers and ship with complete regulatory statements—this builds more trust than any glossy product brochure could ever achieve.
I’ve spoken with dozens of development chemists and project leads who tried to shortcut with unknown-source or distributor-sourced material. Each time, the lessons echo: initial savings rarely match rework, delays, or analytical reruns needed when a batch fails compliance or reproducibility in a critical synthesis. An agrochemical client once told us his team restarted pilot plant runs with our BMTP after losing a week to contaminated third-party supply. The cost in lost time, wasted solvent, and project delays far exceeded any single-sourcing “savings.” These real-world tales, not theory, reinforce why the market keeps coming back for properly made material from an actual source.
For organizations developing therapies or generating high-value intermediates, batch uniformity isn’t a luxury—it’s essential. BMTP’s consistent specification and enhanced stability facilitate smoother scale-up, easier downstream processing, and ultimately, more reliable timelines for new product introduction. The longer companies spend making high-impact, low-yielding molecules, the more they realize that a rock-solid intermediate, with transparent provenance and tight controls, saves more than it costs. We’ve seen our share of last-minute orders, urgent samples, and midnight calls when another supplier failed to deliver at spec; the gratitude from those rescued projects bolsters our entire team’s pride and purpose.
No manufacturer can stand still, and we don’t pretend a once-good process is good forever. As new downstream processes emerge—flow chemistry, microreactors, and biocatalysis among them—we tweak our own methods to support changing needs. Just last quarter, a major customer requested material with even tighter isomeric purity for a pharmaceutical run. We took up that feedback in earnest, adjusting separation steps and running extra QA to squeeze out fractional percentages of byproduct. These process improvements feed directly into our overall product line, so even non-pharma clients benefit over time.
Market trends also matter. The surge in demand for fluorinated building blocks reflects broader pressures in life sciences and materials chemistry: better metabolic profiles, more stable scaffolds, tunable properties for advanced materials. BMTP answers many of these pressures, and direct customer feedback has prompted us to increase reactor throughput while maintaining strict environmental and safety standards. We keep a close watch on input quality, supply reliability, and broader developments in reagent handling technology. Every improvement translates back to more reliable, more versatile BMTP for every customer, old or new.
Behind each drum of BMTP stands a team dedicated to chemistry done right. We work with our hands and minds, seeing not just molecules but the real impacts in every batch, every process, every customer story. Clear, steady communication, transparent practices, and producing the best material we can—these principles matter as much as the chemistry itself. As regulations evolve and scientific frontiers push outward, our promise stays the same: make BMTP that delivers, every time, for those who need it done right, because someone is counting on it at the other end of the line.